Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D010293:Pargyline / Q000627:therapeutic use*; D010389:Pemoline / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use*
D010627:Phenethylamines; D008774:Methylphenidate; D012642:Selegiline; D010389:Pemoline; D010293:Pargyline